Both segregation analysis [27]–[29] and the fact that no major high-risk breast cancer genes have been identified since BRCA2 suggest that additional high-risk alleles are much rarer than mutations in BRCA1 and BRCA2. Exome sequencing might be a very useful tool to identify these very rare high-risk alleles. Here, BRCA1 is linked to breast carcinoma.